US2006166265A1PendingUtilityA1
Survivin-binding proteins, encoding nucleic acids, and methods of use
Est. expiryJan 25, 2021(expired)· nominal 20-yr term from priority
C07K 14/4703C07K 14/4747
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
In accordance with the present invention, there are provided novel Survivin-binding-proteins (SBPs). Nucleic acid sequences encoding such proteins and assays employing same are also disclosed. The invention SBPs can be employed in a variety of ways, for example, for the production of anti-SBP antibodies thereto, in therapeutic compositions and in bioassays methods employing such proteins and/or antibodies. Also provided are transgenic non-human mammals that express the invention protein.
Claims
exact text as granted — not AI-modified1 . An isolated nucleic acid molecule encoding an SBP1 polypeptide, or functional fragment thereof, selected from the group consisting of:
(a) a nucleic acid molecule encoding a polypeptide comprising amino acids 1-91 of SEQ ID NO: 14, wherein said polypeptide binds Survivin; (b) a nucleic acid molecule encoding a polypeptide comprising amino acids 85-125 of SEQ ID NO:14, wherein said polypeptide enhances cyclin B1/cdc2 kinase activity; (c) a nucleic acid molecule encoding SEQ ID NO: 14; and (d) a nucleic acid molecule that hybridizes to the complement of the nucleic acid molecule of (a), (b) or (c) under highly stringent hybridization conditions, and encodes a polypeptide that binds Survivin or enhances cyclin B1/cdc2 kinase activity.
2 . The isolated nucleic acid molecule of claim 1 , wherein said polypeptide is encoded by a nucleotide sequence selected from the group consisting of:
(a) nucleotides 1-273 of SEQ ID NO:13; (b) nucleotides 253-375 of SEQ ID NO:13; and (c) SEQ ID NO: 13
3 . A vector comprising the nucleic acid molecule of claim 1 .
4 . A recombinant cell comprising the nucleic acid molecule of claim 1 .
5 . An oligonucleotide comprising at least 17 nucleotides capable of specifically hybridizing with a nucleotide sequence set forth in SEQ ID NO: 13 or its complement.
6 . The oligonucleotide of claim 5 , wherein said oligonucleotide is labeled with a detectable label.
7 . A kit for detecting the presence of an SPB1 nucleic acid molecule, comprising at least one oligonucleotide according to claim 5 .
8 - 11 . (canceled)
12 . A method for expression of an SBP1 polypeptide, said method comprising culturing the cell of claim 4 under conditions suitable for expression of said SBP1.
13 - 34 . (canceled)Join the waitlist — get patent alerts
Track US2006166265A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.